Clinical Trials Directory

Trials / Completed

CompletedNCT00930670

Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
320 (actual)
Sponsor
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is conflicting evidence in the literature suggesting that the use of proton pump inhibitors (PPIs), and/or some statins can interfere with clopidogrel antiplatelet effect and result in adverse cardiovascular outcomes in patients treated with coronary artery stents and dual antiplatelet therapy. The primary aim of the study is to determine the effect of various currently used PPI on platelet aggregation in patients undergoing percutaneous coronary intervention (PCI) and treated with dual antiplatelet therapy. The secondary aim of the study is to evaluate how statins and 2C19\*2 polymorphism modulate the effect of PPI on clopidogrel efficacy.

Conditions

Interventions

TypeNameDescription
DRUGRosuvastatin-omeprazoleRosuvastatin 20 mg for 1 month. Then rosuvastatin 20mg and omeprazole 20mg for 11 months
DRUGRosuvastatin-pantoprazoleRosuvastatin 20 mg for 1 month, then rosuvastatin 20 mg and pantoprazole 40 mg for 11 months
DRUGRosuvastatin-esomeprazoleRosuvastatin 20 mg for 1 month, then rosuvastatin 20 mg and esomeprazole 40 mg for 11 months
DRUGRosuvastatin-ranitidineRosuvastatin 20 mg for 1 month, then rosuvastatin 20 mg and ranitidine 300mg for 11 months
DRUGAtorvastatin-omeprazoleAtorvastatin 80mg for 1 month, then atorvastatin 80 mg and omeprazole 20 mg for 11 months
DRUGAtorvastatin-pantoprazoleAtorvastatin 80mg for 1 month, then atorvastatin 80 mg and pantoprazole 40 mg for 11 months
DRUGAtorvastatin-esomeprazoleAtorvastatin 80mg for 1 month, then atorvastatin 80 mg and esomeprazole 40 mg for 11 months
DRUGAtorvastatin-ranitidineAtorvastatin 80mg for 1 month, then atorvastatin 80 mg and ranitidine 300mg for 11 months

Timeline

Start date
2009-06-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2009-06-30
Last updated
2012-02-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00930670. Inclusion in this directory is not an endorsement.